$0.9300
0.011.09%
At close: -
Comments
Loading...
Cannara Biotech Analyst Ratings and Price Targets | OTC:LOVFF | Benzinga
Cannara Biotech Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Cannara Biotech Corp from these most-recent analyst ratings.
Analyst Ratings for Cannara Biotech
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Cannara Biotech (LOVFF) stock?
There is no price target for Cannara Biotech
What is the most recent analyst rating for Cannara Biotech (LOVFF)?
There is no analyst for Cannara Biotech
When was the last upgrade for Cannara Biotech (LOVFF)?
There is no last upgrade for Cannara Biotech
When was the last downgrade for Cannara Biotech (LOVFF)?
There is no last downgrade for Cannara Biotech.
When is the next analyst rating going to be posted or updated for Cannara Biotech (LOVFF)?
There is no next analyst rating for Cannara Biotech.
Is the Analyst Rating Cannara Biotech (LOVFF) correct?
There is no next analyst rating for Cannara Biotech.
Browse analyst ratings and price targets on all stocks.